Parenteral iron therapy options

被引:135
作者
Silverstein, SB
Rodgers, GM [1 ]
机构
[1] Univ Utah, Hlth Sci Ctr, Div Hematol, Dept Pharm Serv, Salt Lake City, UT 84132 USA
[2] Univ Utah, Hlth Sci Ctr, Dept Med, Salt Lake City, UT 84132 USA
[3] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA
关键词
iron deficiency; iron therapy;
D O I
10.1002/ajh.20056
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Parenteral iron therapy is occasionally necessary for patients intolerant or unresponsive to oral iron therapy, for receiving recombinant erythropoietin therapy, or for use in treating functional iron deficiency. There are now three parenteral iron products available: iron dextran, ferric gluconate, and iron sucrose. We summarize the advantages and disadvantages of each product, including risk of anaphylaxis and hypersensitivity, dosage regimens, and costs. The increased availability of multiple parenteral iron preparations should decrease the need to use red cell transfusions in patients with iron-deficiency anemia. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:74 / 78
页数:5
相关论文
共 20 条
  • [1] [Anonymous], 1997, Am J Kidney Dis, V30, pS192
  • [2] Lack of reaction to ferric gluconate in hemodialysis patients with a history of severe reaction to iron dextran
    Bastani, B
    Rahman, S
    Gellens, M
    [J]. ASAIO JOURNAL, 2002, 48 (04) : 404 - 406
  • [3] BECKIE M, 2002, KIDNEY INT, V61, P1830
  • [4] Intravenous iron sucrose: Establishing a safe dose
    Chandler, G
    Harchowal, J
    Macdougall, IC
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (05) : 988 - 991
  • [5] Efficacy and safety of iron sucrose for iron deficiency in patients with dialysis-associated anemia: North American clinical trial
    Charytan, C
    Levin, N
    Al-Saloum, M
    Hafeez, T
    Gagnon, S
    Van Wyck, DB
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (02) : 300 - 307
  • [6] Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients
    Coyne, DW
    Adkinson, NF
    Nissenson, AR
    Fishbane, S
    Agarwal, R
    Eschbach, JW
    Michael, B
    Folkert, V
    Batlle, D
    Trout, JR
    Dahl, N
    Myirski, P
    Strobos, J
    Warnock, DG
    [J]. KIDNEY INTERNATIONAL, 2003, 63 (01) : 217 - 224
  • [7] Is iron gluconate really safer than iron dextran?
    Eichbaum, Q
    Foran, S
    Dzik, S
    [J]. BLOOD, 2003, 101 (09) : 3756 - 3757
  • [8] Sodium ferric gluconate complex in sucrose: Safer intravenous iron therapy than iron dextrans
    Faich, G
    Strobos, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 33 (03) : 464 - 470
  • [9] The safety of intravenous iron dextran in hemodialysis patients
    Fishbane, S
    Ungureanu, VD
    Maesaka, JK
    Kaupke, CJ
    Lim, V
    Wish, J
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (04) : 529 - 534
  • [10] The comparative safety of intravenous iron dextran, iron saccharate, and sodium ferric gluconate
    Fishbane, S
    Kowalski, EA
    [J]. SEMINARS IN DIALYSIS, 2000, 13 (06) : 381 - 384